From: A review on the role of cyclin dependent kinases in cancers
Tumor type | Samples | Expression (Tumor vs. Normal) | Kaplan–Meier analysis (impact of CDK up-regulation) | Association of high expression CDK with clinical data | References |
---|---|---|---|---|---|
Adrenocortical carcinoma | GEO and TCGA databases | Up-regulation of CENPF (which interacts with CDK1) | Shorter OS | different immune cell populations, and high TMB/MSI score | [6] |
Bladder cancer | GEO database 5 bladder cancer tissues and 35 normal tissues | Up-regulation of PVT1 (which regulated CDK1) Up-regulation of CDK1 | _ | _ | [7] |
TCGA dataset | Up-regulation of TFCP2L1 | Shorter OS | tumor grade, lymphovascular and muscularis propria invasion, and distant metastasis | [8] | |
GEO database (GSE71576) TCGA database: 412 BC patients GEO database (GSE13507: 165 primary bladder cancer samples, 58 ANCTs, 23 recurrent bladder tumor tissues and 10 normal bladder mucosae) | Up-regulation of CDK1 | _ | tumor grade and recurrence | [70] | |
Breast cancer | 46 PTANCT | Up-regulation of RBM7 (which regulates up-regulation of CDK1) | Shorter OS | _ | [19] |
TCGA dataset 72 PTANCT | Up-regulation of KIAA1429 | _ | advanced clinical stages | [10] | |
Oncomine database and GEPIA dataset | Up-regulation of CDK1 | Shorter OS, RFP, and PPS | advanced tumor stage | [69] | |
GSE42568, GSE45827, and GSE124646 (244 BC tissues and 28 normal breast tissues) | Up-regulation of CDK1 | _ | _ | [11] | |
8 PTANCT | Up-regulation of UBAP2L | _ | _ | [12] | |
17 PTANCT | Down-regulation of miR-424 | _ | _ | [17] | |
GEO database (GSE21422 and GSE21974) | Up-regulation of NUSAP1 (which regulates CDK1) | _ | _ | [18] | |
GEO database (GSE21422, GSE42568 and GSE45827) | Up-regulation of CDK1 | Shorter OS | _ | [71] | |
Cervical cancer | GEO database 60 PTANCT | Up-regulation of CDK1 | _ | _ | [20] |
TCGA dataset (two courts 100 and 120 patients) 31 PTANCT | Up-regulation of NCK1-AS1 (which regulates CDK1) | Shorter OS | _ | [21] | |
Cholangiocarcinoma | 54 cholangiocarcinoma patients | Up-regulation of CDK1 | Shorter OS | lymph node metastasis and the clinical stage | [22] |
74 CCA tissues and 5 normal tissues | Up-regulation of PSMC2 (which regulates CDK1) | _ | advanced tumor grades | [23] | |
Colorectal cancer | TCGA dataset | Up-regulation of CDK1 | _ | _ | [15] |
TCGA database 22 PTANCT 108 CRC patients | Down-regulation of miR-378a-5p (which targets CDK1) Up-regulation of CDK1 | _ | tumors in the right colon, lymph node metastasis, and TNM stage | [24] | |
99 cancerous tissues and 76 normal tissues | Up-regulation of DPP3 | Shorter OS | lymphatic metastases, stage, positive numbers of lymph nodes | [25] | |
GSE8671, GSE74602, and TCGA datasets 12 tumor tissues and 12 normal tissues | Up-regulation of SNHG4 (which regulated CDK1) | _ | lymphatic or distal metastatic stage | [26] | |
GEO database (GSE126092) | Up-regulation of CDK1 | Shorter OS | _ | [72] | |
TCGA database (459 colon cancer samples and 41 normal samples) 5 PTANCT | Up-regulation of NFE2L3 | _ | _ | [27] | |
GEO database (GSE21815, GSE106582, and GSE41657) | Up-regulation of CDK1 | Shorter OS | gender, tumor type, TNM stage, and KRAS gene mutation | [73] | |
Endometrial carcinoma | 42 PTANCT | Up-regulation of CDK1 | _ | _ | [29] |
Esophageal squamous cell carcinoma | 151 ESCC tissues and 138 normal esophageal tissues 8 PTANCT 664 ESCC patients and 1733 control tissues | Up-regulation of CDK1 | _ | _ | [74] |
Gastric cancer | 80 PTANCT GEO database (GSE99416 (6 PTANCT)) | Up-regulation of CASC11 (which regulated CDK1) | _ | _ | [75] |
GEPIA2 database 50 PTANCT 246 patients | Up-regulation of ESRRA | Shorter OS | tumor invasion extent, lymph node/distant metastases and TNM stage | [32] | |
Oncomine database, TCGA database and GTEx project (9736 tumor samples and 8726 normal samples) | Up-regulation of CDK1 and CDCA5 | _ | _ | [33] | |
Glioma | TCGA database (511 low‐grade glioma cases and 156 glioblastoma cases) 30 glioma tissues and 7 normal tissues | Up-regulation of FOXD2-AS1 (which regulated CDK1) | Shorter OS | _ | [36] |
Hepatocellular carcinoma | 3 HCC patients | Up-regulation of CDK1 | Shorter OS | _ | [37] |
ONCOMINE database AND TCGA, ICGC, and GEO databases | Up-regulation of CDK1 | _ | immune cell infiltration | [76] | |
GEO database (GSE121248, GSE45267 and GSE84402 (132 tumor tissues and 90 normal tissues)) | Up-regulation of CDK1 | Shorter OS | _ | [77] | |
178 PTANCT TCGA database | Up-regulation of DEPDC1B (which plays its role via CDK1) | _ | pathologic T/N, tumor stage, and gender | [38] | |
GEO database (GSE55092, GSE84044 and GSE121248 (119 HBV-related HCC samples and 252 HBV-related non-tumor samples)) | Up-regulation of CDK1 | _ | clinical grading of HCC | [78] | |
GEO database (GSE113850) 14 PTANCT | Up-regulation of CDK1 | Shorter OS and DFS | HCC occurrence, pathological stages, and survivorship curve | [40] | |
GEO database (GSE14520: 225 HCC tissues and 220 normal tissues) TCGA database: 365 patients 59 PTANCT | Up-regulation of CDK1 | Shorter OS | _ | [79] | |
80 PTANCT | Up-regulation of SNORD52 (which regulated CDK1) | Shorter OS and RFS | microvascular invasion and TNM stage | [41] | |
Hepatocellular carcinoma | GEO database (GSE27635 and GSE28248) | Up-regulation of CDK1 | Shorter OS | _ | [80] |
GEO database (GSE84402, GSE101685, and GSE112791) TCGA dataset | Up-regulation of CDK1 | _ | tumor-infiltrate lymphocytes | [81] | |
Lung cancer | lung tissues | Up-regulation of CDK1 | Shorter OS | _ | [43] |
GEPIA database (9,736 tumor samples and 8,587 normal controls) 8 PTANC | Up-regulation of CDK1 | Shorter OS | advanced tumor stages | [82] | |
30 PTANC | Up-regulation of CASC11 (which regulated CDK1) | _ | _ | [44] | |
TCGA database (991 tumor tissues and 91 normal tissues) 14 pairs of KRASmut tumor tissues and ANCTs | Down-regulation of miR-34c-3p (which targets CDK1) | _ | _ | [45] | |
64 PTANC | Up-regulation of NCK1-AS1 (which regulated CDK1) | _ | tumor size, TNM stage and lymph node metastasis | [46] | |
GEO database (GSE6044 and GSE118370) | Up-regulation of CDK1 | Shorter OS and DFS | tumor stages and relative abundance of tumor infiltrating immune cells | [83] | |
50 PTANC | Up-regulation of TMPO-AS1 (which regulated CDK1) | Shorter OS | _ | [49] | |
78 PTANC | Down-regulation of miR-181a | _ | histological grade, N status and TNM stage | [50] | |
GEO database (5 different microarray datasets: 330 samples) | Up-regulation of CDK1 | Shorter OS | _ | [84] | |
Nasopharyngeal carcinoma | 99 NPC patients and 46 normal tissues | Down-regulation of miR-195-3p (which sponged CDK1) | _ | tumor grade, lymph node metastasis, clinical stage, and radioresistance | [58] |
Ovarian cancer | 20 tumor tissues and 12 normal tissues | Up-regulation of UBE2C | Shorter OS and PFS | _ | [59] |
GEO database (GSE14407, GSE29450, and GSE54388) | Up-regulation of CDK1 | Shorter OS | _ | [85] | |
TCGA dataset 62 PTANC | Up-regulation of TONSL-AS1 (which regulates CDK1) | Shorter OS | _ | [61] | |
11 benign ovarian tumors, 8 borderline ovarian tumors, 99 ovarian cancer tissues and 15 normal ovary tissues | Up-regulation of DLEU1 (which regulated CDK1) in ovarian cancer tissues | _ | differentiation and FIGO staging | [62] | |
Pancreatic ductal adenocarcinoma | 99 PDAC tissues and 71 normal pancreatic tissues | Up-regulation of CDK1 | Shorter OS | tumor size and histological grade | [86] |
GEO database (GSE46234, GSE71989, and GSE107610) | Up-regulation of CDK1 | Shorter OS and DFS | advanced tumor stage | [87] | |
Prostate cancer | TCGA database (499 prostate cancer and 52 adjacent tissues) | Up-regulation of TPX2 | Shorter OS | high Gleason grade | [66] |
TCGA and GEO databases 149 prostate cancer patients | Up-regulation of ABCC5 | Shorter OS and PFS | tumor stage | [67] | |
Prostate cancer | 1,461 patients and 510 normal samples | Down-regulation of miR-205 (which targeted CDK1) | _ | bone metastasis | [88] |
Rhabdomyosarcoma | GEO database 66 samples (GSE16382 [N = 8] and GSE66533 [N = 58)) and 16 normal striated muscle tissues (GSE39454 [N = 5], GSE17674 [N = 5] and GSE38417 [N = 6]) | Up-regulation of CDK1 | _ | _ | [89] |
Sebaceous gland carcinoma of the eyelid | 3 SGC patients and 1 sebaceous adenoma case | Up-regulation of CDK1 in SGC patients | _ | _ | [90] |
Thyroid cancer | Two tissue microarrays (THC961 and THC1021) (125 cancerous thyroid tissues and 23 non-cancerous thyroid tissues) 46 cancerous thyroid tissues and 64 non-cancerous thyroid tissues 171 cancerous thyroid tissues and 87 non-cancerous thyroid tissues 16 gene microarrays (419 cancerous thyroid tissues and 269 non-cancerous thyroid tissues) | Up-regulation of CDK1 | _ | _ | [91] |